| Bioactivity | 13-Dihydrocarminomycin (compound D788-12) is the major metabolite of the antitumor antibiotic Carminomycin (HY-B2171). 13-Dihydrocarminomycin has weak antitumor activity[1][2]. |
| Invitro | 13-Dihydrocarminomycin (compound D788-12; 0-1 mM; 48 h) 抑制 L1210 细胞的生长，其 IC50 值为 0.06 µg/mL (120 µM)[1]。 Cell Viability Assay[1] Cell Line: |
| Name | 13-Dihydrocarminomycin |
| CAS | 62182-86-9 |
| Formula | C26H29NO10 |
| Molar Mass | 515.51 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yoshimoto A, et al. Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. II. New anthracycline metabolites produced by a blocked mutant strain RPM-5. J Antibiot (Tokyo). 1993 Jan;46(1):56-64. [2]. Poteshnykh AV, et al. Determination of carminomycin and its basic metabolite 13-dihydrocarminomycin by a highly efficient liquid chromatographic method with a fluorescent detector. Antibiotiki. 1982 Nov;27(11):820-3. |
13-Dihydrocarminomycin
CAS: 62182-86-9 F: C26H29NO10 W: 515.51
13-Dihydrocarminomycin (compound D788-12) is the major metabolite of the antitumor antibiotic Carminomycin (HY-B2171). 1
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.